COST OF EPIDIOLEX VS WHOLE PLANT CANNABIS FOR TREATMENT RESISTANT EPILEPSY

As many of you have heard, Epidiolex, a nearly pure CBD anti-epileptic made by GW Pharmaceuticals has been approved by the FDA and will probably launch sales mid 2019.

The cost for an average patient for one year is over $32,000.

This is on par with other anti-epileptics, but is certainly an astonishing cost when you compare this cost to the cost of whole plant CBD at it’s therapeutic dose.

I specifically say “whole plant cannabis” because it always requires far less CBD than CBD isolates, and Epidiolex is no exception although not a pure isolate. So when comparing cost, it is essential to compare to the average cost of whole plant CBD at the dose where it is effective. In my experience, I very rarely use more than 100 mg per day in divided doses sublingually for intractable seizures.

Not only is whole plant cannabis less expensive at around $5,000 per year, it requires a lower dose and I believe, as with other whole plant vs “isolate” studies, the whole plant CBD will prove to be more effective.

This may have a huge impact on the stock, as the more patients who go “whole plant”, the less sales to GW. Even with insurance paying for it, it is likely the co-pay will be as much as the whole plant cost for the year.

I suppose this is good news for the “artisanal” cannabis medicine creator, but if less and less CBD is available and so few doctors are involved, the Pharmaceutical route may still win out.

http://globenewswire.com/news-release/2018/08/07/1548402/0/en/GW-Pharmaceuticals-plc-Reports-Fiscal-Third-Quarter-2018-Financial-Results-and-Operational-Progress.html

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

WHILE CONSIDERING CHEMOTHERAPY…

Dr Frankel talks about chemotherapy, it's issues/side effects, and how cannabis can alleviate some of those issues, prevent others, and help enhance the effectiveness of the chemo. He uses a few patient cases to illustrate his approach.

DR MERCOLA INTERVIEWS DR ALLAN FRANKEL

Dr. Mercola interviews Dr. Frankel on many areas of medical cannabis. Topics discussed range from THCV, home growing, dabbing issues, Cannabis Hyperemesis, Myasthenia Gravis and the future of medical cannabis.

EPIDIOLEX VERSUS WHOLE PLANT CANNABIS CBD

Dr Frankel has long been a proponent of using whole plant, cannabis derived CBD products and a recent case in which a patient had less effective results when switching to a prescribed CBD isolate further cemented his stance on what works best for patients

CAN CANNABIS CAUSE ARTERIAL DAMAGE?

Dr Frankel gives his thoughts and counterpoints on the potential issue of cannabis causing arterial damage after some articles were recently circulating about this subject.